Briley Annette L, Barr Suzanne, Badger Shirlene, Bell Ruth, Croker Helen, Godfrey Keith M, Holmes Bridget, Kinnunen Tarja I, Nelson Scott M, Oteng-Ntim Eugene, Patel Nashita, Robson Stephen C, Sandall Jane, Sanders Thomas, Sattar Naveed, Seed Paul T, Wardle Jane, Poston Lucilla
Division of Women's Health, Women's Health Academic Centre, King's College London and King's Health Partners, 10th floor, North Wing, St,Thomas' Hospital, London SE1 7EH, UK.
BMC Pregnancy Childbirth. 2014 Feb 18;14:74. doi: 10.1186/1471-2393-14-74.
Despite the widespread recognition that obesity in pregnant women is associated with adverse outcomes for mother and child, there is no intervention proven to reduce the risk of these complications. The primary aim of this randomised controlled trial is to assess in obese pregnant women, whether a complex behavioural intervention, based on changing diet (to foods with a lower glycemic index) and physical activity, will reduce the risk of gestational diabetes (GDM) and delivery of a large for gestational age (LGA) infant. A secondary aim is to determine whether the intervention lowers the long term risk of obesity in the offspring.
METHODS/DESIGN: Multicentre randomised controlled trial comparing a behavioural intervention designed to improve glycemic control with standard antenatal care in obese pregnant women.Inclusion criteria; women with a BMI ≥30 kg/m2 and a singleton pregnancy between 15+0 weeks and 18+6 weeks' gestation. Exclusion criteria; pre-defined, pre-existing diseases and multiple pregnancy. Randomisation is on-line by a computer generated programme and is minimised by BMI category, maternal age, ethnicity, parity and centre. Intervention; this is delivered by a health trainer over 8 sessions. Based on control theory, with elements of social cognitive theory, the intervention is designed to improve maternal glycemic control. Women randomised to the control arm receive standard antenatal care until delivery according to local guidelines. All women have a 75 g oral glucose tolerance test at 27+0- 28+6 weeks' gestation.Primary outcome; Maternal: diagnosis of GDM, according to the International Association of Diabetes in Pregnancy Study Group (IADPSG) criteria. Neonatal; infant LGA defined as >90th customised birth weight centile.Sample size; 1546 women to provide 80% power to detect a 25% reduction in the incidence of GDM and a 30% reduction in infants large for gestational age.
All aspects of this protocol have been evaluated in a pilot randomised controlled trial, with subsequent optimisation of the intervention. The findings of this trial will inform whether lifestyle mediated improvement of glycemic control in obese pregnant women can minimise the risk of pregnancy complications.
Current controlled trials; ISRCTN89971375.
尽管人们普遍认识到孕妇肥胖与母婴不良结局相关,但尚无经证实可降低这些并发症风险的干预措施。这项随机对照试验的主要目的是评估,对于肥胖孕妇,基于改变饮食(改为血糖生成指数较低的食物)和身体活动的综合行为干预是否会降低妊娠期糖尿病(GDM)风险和巨大儿(LGA)分娩风险。次要目的是确定该干预措施是否会降低后代肥胖的长期风险。
方法/设计:多中心随机对照试验,比较旨在改善血糖控制的行为干预与肥胖孕妇的标准产前护理。纳入标准:体重指数(BMI)≥30kg/m²且单胎妊娠、孕周在15⁺⁰周和18⁺⁶周之间的女性。排除标准:预先定义的既往疾病和多胎妊娠。通过计算机生成程序进行在线随机分组,并按BMI类别、产妇年龄、种族、产次和中心进行最小化处理。干预措施:由健康培训师进行8次授课。基于控制理论并融入社会认知理论的元素,该干预旨在改善孕妇血糖控制。随机分配至对照组的女性根据当地指南接受标准产前护理直至分娩。所有女性在妊娠27⁺⁰至28⁺⁶周时进行75g口服葡萄糖耐量试验。主要结局:母体:根据国际妊娠糖尿病研究组(IADPSG)标准诊断为GDM。新生儿:婴儿LGA定义为出生体重定制百分位数>第90百分位数。样本量:1546名女性,以提供80%的检验效能,检测GDM发病率降低25%以及巨大儿减少30%。
本方案的所有方面均已在一项试点随机对照试验中进行了评估,并随后对干预措施进行了优化。该试验的结果将为肥胖孕妇通过生活方式介导改善血糖控制是否能将妊娠并发症风险降至最低提供依据。
当前对照试验;ISRCTN89971375。